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region of one subunit work together with the catalyticMammalian Fatty Acid Synthase:
domains from the C-terminal region of the other subunit.Closure on a Textbook This widely accepted mechanism and the associated
structural model only started to be seriously questionedMechanism?
after Smith and his collaborators succeeded in express-
ing recombinant FAS in insect cells and began to use
site-directed mutagenesis to knock out individual active
sites [6]. More importantly, they developed a tediousMammalian fatty acid synthase is a classic example
but reproducible methodology for scrambling togetherof a chain-building multienzyme. A cornerstone of its
the subunits of two different purified FAS mutants andmechanism has been the obligatory collaboration of
then allowing them to redimerize [7, 8]. Now, they couldtwo identical subunits, with fatty acyl intermediates
interrogate the heterodimers for activity, and in a meticu-transferring between them. Now, fresh evidence has
lous series of complementation experiments they builtupset this view.
a detailed map of the functional relationships between
individual domains of the FAS dimer. Later, affinity tags
Classic biochemical studies on the enzymes of fatty acid were introduced so that the heterodimers could be sepa-
biosynthesis by the research groups of Lynen, Bloch, rated away from the homodimeric parents before the
Wakil, and others have given us an enduring and satis- kinetic analysis was done [9]. The results of this comple-
fying picture of the individual enzyme activities involved mentation analysis soon unveiled a major surprise: the
and of the way in which they are orchestrated to produce dehydratase domain makes functional contact with the
fatty acids. The growing chain, attached to the active ACP in its own polypeptide chain, although separated
site of a ketosynthase (KS) enzyme, is condensed with from it by some 1200 amino acids [8]. This finding is
a malonyl unit (covalently attached to an acyl carrier incompatible with the classical structural model.
protein [ACP]) through the action of an acyltransferase Meanwhile, advances in our understanding of the re-
(AT) to produce a -ketoacyl product on the ACP with lated process of polyketide biosynthesis were shedding
release of carbon dioxide; the ketoacyl moiety is then additional and unexpected light on FAS mechanism and
reduced to saturated acyl by the successive action of structure. Production of the complex polyketide antibi-
ketoreductase, dehydratase, and enoylreductase en- otic erythromycin A by the bacterium Saccharopoly-
zymes, and the lengthened chain hops back to the KS spora erythraea had been shown as early as 1990 [10]
to initiate the next cycle. For the mammalian and yeast to involve giant multienzymes akin to mammalian FAS,
fatty acid synthases, the analysis was particularly chal- in which each cycle of chain extension is catalyzed by
lenging because (in contrast to bacterial fatty acid syn- a different set or module of FAS-related activities. Strik-
thase) the individual enzymes were found to be cova- ingly, the order and identity of the active sites along
lently associated as domains of a large multifunctional the polypeptide chain was identical in each module to
protein, but by the late 1980s it was possible to write a comparable active sites of the mammalian FAS [10–12].
coherent account of the currently accepted mechanism In 1996, a “helical” model was proposed for modular
[1, 2]. One of the key features of the mechanism had PKSs in which the multienzymes were homodimeric,
been revealed by analysis of the rapid stochiometric and within each module the subunits interacted both
inhibition of the mammalian fatty acid synthase by the head-to-head (KS in contact with KS, ACP in contact
bifunctional chemical 1,3-dibromopropan-2-one [3]. In with ACP) and head-to-tail (KS in contact with ACP of
the inhibited multienzyme, it appeared that the active- the opposite subunit) [13]. This model, based on the
site cysteine of each KS enzyme was crosslinked specif- results of hydrodynamic experiments, on limited prote-
ically to the ACP on the opposite subunit of a homodi- olysis and chemical crosslinking, was supported by the
mer. Together with evidence from electron microscopy results of qualitative mutant complementation studies
and neutron scattering [4], this immediately suggested based on the Smith approach [14]. In particular, since
why the multienzyme polypeptide needed to be dimeric: ACP-thioesterase didomain fragments were also homo-
the ACP and KS domains on the same polypeptide were dimeric, the modular PKS structure had to be coiled and
simply too far apart to interact. Indeed, when monomeric compact compared to the classic FAS model.
versions of the mammalian FAS were made, they were More recent mutant complementation studies in
confirmed to be wholly inactive in overall synthesis, al- Smith’s laboratory showed that a single KS or AT domain
though certain individual activities were still detectable could “service” [15] the ACP domains on both subunits
using model substrates. Also, limited proteolysis of puri- of FAS [16]. This in turn prompted a reinvestigation of
fied FAS protein, which severs the flexible linkers be- the classical crosslinking experiment with 1,3-dibromo-
tween the enzymatic domains, was shown to give pat- propan-2-one, and a previously overlooked minor prod-
terns of smaller fragments, which could be readily uct could be characterized as representing chemical
interpreted in terms of a model in which two identical crosslinking of KS and ACP active sites within the same
polypeptides, each containing seven active sites, lie subunit [17]. Clearly, the FAS dimer is also coiled and
head-to-tail in an extended planar arrangement [5]. This compact [18].
The most recent experiments, reported by Smith andsuggests that the catalytic domains in the N-terminal
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Homology Model of KS Domain Dimer
Homology model, created by Nuria Campillo,
Mark Williams, Bojana Popovic, and Tom L.
Blundell, of a KS domain dimer from a modu-
lar PKS, based on FabF of E. coli [20]. Active-
site residues are shown in green; the active-
site loop contributed by the other subunit is
highlighted in blue.
his colleagues in this issue of Chemistry & Biology [19], multienzymes. X-ray crystal structures of (at least appro-
priate portions of) the FAS itself are eagerly awaited tohave set the seal on these insights: when a subunit of
the FAS mutated in each and every one of its seven allow this question to be finally settled. Smith’s findings
also have implications for our understanding of theactive sites was combined in a heterodimer with a wild-
type FAS subunit, the resulting enzyme was found, re- structure and function of the modular PKS systems: the
convergence of the FAS structural model toward thatmarkably, to be capable of synthesizing long chain fatty
acids, and at a very efficient rate—roughly one-third of originally proposed for the modular PKS further under-
lines the profound similarity between the two multien-each of the active sites in a fully functional wild-type
dimer. This result could have been produced if the het- zyme systems.
erodimers of active and inactive subunits reassorted,
but several lines of evidence were used to eliminate the
Peter Leadlay and Abel Baerga-Ortizpossibility that this had occurred. Taken together, these
Department of Biochemistryresults provide compelling evidence for Smith’s view
University of Cambridgethat the textbook model for FAS mechanism and struc-
80 Tennis Court Roadture needs revision. Clearly, a fatty acid can be synthe-
Cambridge CB2 1GAsized even when covalent attachment of intermediates
United Kingdomand extension units is only possible to one of the sub-
units.
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a procedure that allowed crystals to develop a few min-
utes [6]. The streptomycin-aptamer complex adopts an
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Aptamer Structures: A Preview
into Regulatory Pathways? unusually sophisticated structure characterized by a 90
kink between residues C106 and C107 at the bottom of
the lower asymmetrical loop, giving the complex its L
The crystal structure of a streptomycin binding RNA
aptamer displays a novel bipartite fold able to clamp
the antibiotic. In view of the recent findings that
metabolites directly control mRNA translation, we
might expect that similar structures exist in natural
RNAs.
The notion that RNA molecules are able to fold and build
binding pockets for small molecules first emerged when
it was discovered that self-splicing group I introns have
a cofactor [1]. Guanosine was the first of a list of metabo-
lites that interact with high affinity and specificity with
RNA. The same binding site located in the group I intron
core can accommodate the amino acid arginine and
many antibiotics, among them streptomycin, neomycin,
and viomycin [2]. Today it is clear that RNA is a potent
target for therapeutic drugs. In the past year, a plethora
of high-resolution structures of antibiotic-ribosome
complexes shed light into the binding mode and recog-
nition principles of RNA-antibiotic interactions [3].
With the development of in vitro selection procedures,
it became possible to isolate RNA aptamers for probably
every water-soluble ligand, and the small size of these
aptamers made them perfect tools to explore the rules
that govern recognition of small molecules by RNA.
High-resolution structures of several ligand-aptamer
complexes have been determined, demonstrating the
diversity of structural motifs RNA can fold into [4]. Both
simple noncomposite folds that form tight binding pock-
ets as well as complex composite modular shapes can
be found. One important outcome of these studies will
Secondary Structure of the Streptomycin Aptamerbe a database with an extensive repertoire of RNA struc-
The secondary structure of the streptomycin aptamer with the 90tural modules. The streptomycin binding aptamer pre-
kink between bases C106 and C107 is shown. Solid black linessented by Tereshko et al. in this issue of Chemistry &
represent base pairing. Base triples are indicated with orange lines.Biology represents a novel RNA fold with a distinct way
Bases highlighted in dark blue interact directly with streptomycin,
to encapsulate a small molecule [5]. whereas the interaction of G6 and U112 (highlighted in light blue)
To enhance the crystallization procedure, the original with the antibiotic is mediated by a water molecule. Arrows indicate
binding sites of the three metal ions (labeled M1 to M3).aptamer was split into two strands with dangling 5 ends,
